Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 214, Issue 10, Pages 3015-3035Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20162069
Keywords
-
Categories
Funding
- Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung [310030B, 141175]
- Eidgenossische Technische Hochschule Zurich [34/13-1]
- European Research Council [323183]
- European Research Council (ERC) [323183] Funding Source: European Research Council (ERC)
Ask authors/readers for more resources
Type-2 immune responses are well-established drivers of chronic inflammatory diseases, such as asthma, and represent a large burden on public health systems. The transcription factor PPAR gamma is known to promote M2-macrophage and alveolar macrophage development. Here, we report that PPAR gamma plays a key role in both T cells and dendritic cells (DCs) for development of type-2 immune responses. It is predominantly expressed in mouse Th2 cells in vitro and in vivo as well as human Th2 cells from allergic patients. Using conditional knockouts, we show that PPAR gamma signaling in T cells, although largely dispensable for IL-4 induction, is critical for IL-33-driven Th2 effector function in type-2 allergic airway responses. Furthermore, we demonstrate that IL-4 and IL-33 promote up-regulation of PPA gamma. in lung-resident CD11b(+) DCs, which enhances migration to draining lymph nodes and Th2 priming capacity. Thus, we uncover a surprising proinflammatory role for PPAR. and establish it as a novel, important mediator of DC-T cell interactions in type-2 immunity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available